Chereads / Alien complex Ship lost on Earth / Chapter 49 - Cancer specific drugs

Chapter 49 - Cancer specific drugs

If such a dangerous drug is obtained by a terrorist organization or individual, it will cause great damage to the world. If a country exclusively possesses this technology, it will greatly increase that country's combat effectiveness.

 Chen Ning did not want to attract the attention of the Chinese military. He discussed with Chen Hongsheng and asked Niu Niu to greatly reduce the efficacy of the "trauma ointment" and minimize the side effects of the "trauma ointment".

 The result is that the "trauma ointment" has abandoned the original formula and turned into a brand-new trauma treatment drug. Of course, the premise is that it is produced with existing traditional Chinese medicine on the earth as raw materials, and Niu Niu is required to divide the efficacy into three levels, which are 1 of the original formula. /10, 1/20, 1/100 efficacy. Three ointments with different efficacy are named after different medicines.

 The ointment with an efficacy of 1% of the original formula is named "Myogenic Ointment", which can completely heal wounds that do not hurt the internal organs within half an hour; the ointment with an efficacy of 1/20th of the original formula is named "Hemostatic Ointment" ", it can stop bleeding and heal penetrating wounds within 20 minutes; the ointment with one-tenth of the efficacy continues to be called "trauma ointment". It is already a miracle-level special medicine under the current conditions on earth. Chen Ning plans to limit the production of "trauma ointment" and use a portion of it as a reserve stock without putting it on the market.

 On March 28, "Liaodong Xingkong Biopharmaceutical Co., Ltd." was officially established. At the same time, the first batch of 20,000 experimental cancer antibiotic "probiotics" was packed and stored. Three types of ointments for treating wounds are also producing 20,000 experimental tubes each. Liaodong Xingkong Biopharmaceutical Co., Ltd. immediately submitted the preclinical research reports of the four pharmaceuticals and ointments, the process research reports of the raw materials and preparations, and the quality research reports of the raw materials and preparations, and ointments to the State Food and Drug Administration for filing, and also submitted them to the State Food and Drug Administration for filing. Apply for clinical research from the Supervision Bureau. A few hours after the report was submitted, the websites of the Provincial Food and Drug Administration and the State Food and Drug Administration appeared to "approval" Liaodong Xingkong Biopharmaceutical Co., Ltd.'s application for phase 1 clinical trials of "probiotics" and three trauma ointments. Chen Ning immediately sent someone to the capital to collect the approval documents and clinical trial approval number.

 At 10 a.m. on March 29, Liaodong Xingkong Biopharmaceutical Co., Ltd. held a press conference at the Fengjing Marriott Hotel and announced the following information to the reporters attending the conference:

 After several years of experimental research, our company has successfully developed "prebiotics", a specific antibiotic for the treatment of cancer.

 "Prebiotics" are 100% effective in treating early-stage cancer patients and 99% effective in treating late-stage cancer patients.

 Spokesperson Ms. Chen Qiuyu explained that the 99% effectiveness rate is that if the cancer patient does not have organic failure or organ necrosis, the therapeutic effect of "prebiotics" is 100% curable and there will be no recurrence.

 The company will recruit 100 volunteers with advanced cancer from all over the world to participate in the company's clinical trials. Among them, China has a limit of 40 people, other Asian countries have a limit of 20 people, Europe has a limit of 15 people, Americas have a limit of 15 people, and Africa, Australia and New Zealand have a limit of 10 people.

 Each cancer patient volunteer participating in a clinical trial can be accompanied by a relative and a reporter from a well-known media in the patient's locality. It is necessary to bring medical records showing examination and treatment at well-known medical institutions in the country. and allow the company to announce it to the outside world.

 Liaodong Xingkong Biopharmaceutical Co., Ltd. is responsible for the round-trip air tickets and accommodation expenses in Fengjing for three people. It also guarantees that the patient will fully recover and that the treatment is 100% effective. If the treatment is ineffective, a gift of US$100,000 will be given.

 Liaodong Xingkong Biopharmaceutical Co., Ltd. will rent a four-star "Lido Hotel" near Fengjing Pharmaceutical Factory as a accommodation for patients' wards, accompanying personnel, and reporters.

 Liaodong Xingkong Biopharmaceutical Co., Ltd. will apply to the World Health Organization and the China Food and Drug Administration to send personnel to guide and supervise this clinical trial. At the same time, experts and scholars from peers or well-known hospitals are welcome to come to Liaodong Xingkong Biopharmaceutical Co., Ltd. to observe and supervise the entire treatment process.

 Applicants please log in to our company's official website. ./.

 Since "Liaodong Xingkong Biopharmaceutical Co., Ltd." is just a newly established small company, it is unknown. Therefore, there were very few reporters attending this press conference, only eight young people including Liao Ruochenxing.

 However, Ms. Chen Qiuyu, who served as the company's spokesperson, was not disappointed because of the small number of reporters, nor did she neglect the few reporters who gave the company face. She completed the press conference step by step according to the procedures of the reception. .

 After the press conference, on behalf of the company, Ms. Chen Qiuyu presented each of the young reporters present with a special company card.

 The promise behind the card is that the company will treat the card holder's cancer disease free of charge, subject to cure. The eight reporters who received the card were very disappointed that Star Company did not pay retouching fees, and they had already decided not to report the news, or to just give them headlines without content.

 Three of the reporters felt that the contents of the gift cards were unlucky, and after walking out of the reception venue, they threw the cards into the trash can next to the door. The huge pie unexpectedly landed on the floor of the Marriott Hotel where the trash was being cleaned at the time. On the body of a 50-year-old cleaning lady named Zhang.

 Aunt Zhang saw that the cards thrown away by the three people were exquisitely made, so she put the three special cards into the card holder that only had one bank stored value card, filling the space of the card holder so that the card holder would not look too shabby. Her unintentional move to satisfy her own vanity enabled her family to escape from poverty a month later, and she bought more than 100 square meters of real estate and a car worth hundreds of thousands of yuan each for herself and her soon-to-be-married son. Volkswagen off-road vehicle.

 When "probiotics" were at their peak, these eight scandals made the headlines of the Beijing Evening News and were reprinted by various print media, TV media and online media, becoming a legend on the streets.

 The three reporters who casually threw away the special cards were dubbed "the most stupid people in history" by people familiar with the matter. They live in regret every day, which greatly affects their work. Within the next year, one reporter could not bear the psychological pressure and resigned, and the other two reporters also changed careers and stopped being journalists.

 Less than an hour after the press conference, the world's major comprehensive websites, professional medical websites, and websites of famous medical institutions all "reprinted" the news that "Star Pharmaceuticals Company" has successfully developed a special drug "probiotics" for the treatment of cancer. As well as the details of the company's recruitment of volunteers with terminal cancer from countries around the world.

 The number of clicks on this news on major comprehensive websites was far higher than that of other hot news, and there were countless followers. It seemed that the whole world was shocked by this news. But how this popular phenomenon came to be known is only known by Chen Ning and several people involved.